Drug Profile
Finasteride - Polichem
Alternative Names: ALM-12845; Finjuve; P-3074Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Polichem
- Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors; Testosterone antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Alopecia
Most Recent Events
- 01 Nov 2021 Hikma Pharmaceuticals enters an exclusive licensing agreement with Almirall to commercialise FinjuveTM in Middle East and North Africa
- 01 Nov 2021 Registered for Alopecia in Portugal, Luxembourg, Germany, Italy, prior to November 2021 (Topical)
- 29 Oct 2019 Almirall expects approval of finasteride for androgenic alopecia in the EU in 2020 or early 2021